Childhood Myopia Part I: Contemporary Treatment Options
Investigative Ophthalmology & Visual Science · 27.06.2025 · 66 (7) · 6
DOI: 10.1167/iovs.66.7.6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 27.06.2025. Verfasst von Safal Khanal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Optometry and Vision Science, University of Alabama at Birmingham, Birmingham, Alabama, United States. Hauptthemen laut MEDLINE: Myopia, Orthokeratologic Procedures, Eyeglasses, Refraction, Ocular. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Optometry and Vision Science, University of Alabama at Birmingham, Birmingham, Alabama, United States.
- Southern California College of Optometry, Marshall B. Ketchum University, Fullerton, California, United States.
- School of Physics and Clinical and Optometric Sciences, Technological University Dublin, Dublin, Ireland.
- Centre for Eye Research Ireland (CERI), Technological University Dublin, Grangegorman, Ireland.
Förderung
- NEI NIH HHS
Zitieren
APA
Khanal, S., Tomiyama, E. S., & Harrington, S. C. (2025). Childhood Myopia Part I: Contemporary Treatment Options. Investigative Ophthalmology & Visual Science, 66(7), 6. https://doi.org/10.1167/iovs.66.7.6
Vancouver
Khanal S, Tomiyama ES, Harrington SC. Childhood Myopia Part I: Contemporary Treatment Options. Investigative Ophthalmology & Visual Science. 2025;66(7):6. doi:10.1167/iovs.66.7.6
BibTeX
@article{Khanal2025,
author = {Khanal, Safal and Tomiyama, Erin S and Harrington, Síofra C},
title = {Childhood Myopia Part I: Contemporary Treatment Options},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
volume = {66},
number = {7},
pages = {6},
doi = {10.1167/iovs.66.7.6}
}
EUVIMED